Tosoh to Increase Production Capacity of Separation and Purification Media
Tosoh Corporation has announced it will increase the production capacity of separation and purification media TOYOPEARL®and TSKgel® PW at its Nanyo Complex (Shunan City, Yamaguchi Prefecture) in response to the growing demand for antibody and oligonucleotide drug purification.

Symbolic image
pixabay.com
Separation and purification media are key products of Tosoh’s Bioscience Division and are used in the purification process of biopharmaceutical manufacturing as well as other processes. One of the critical applications is the purification of antibody-derived molecules. Besides this still growing market, demand for biopharmaceuticals is expanding to gene therapies, RNA-based vaccines and drugs, and other modalities. The oligonucleotide drug market is growing rapidly, leading to active investment in new development and manufacturing, and Tosoh provides high-resolution resins with superior productivity for such therapeutics. To meet the increased demand for all those different applications, Tosoh will increase production capacity by approximately 70 % to ensure a stable supply.
The company continues to invest aggressively not only in separation and purification media but also in pre-packed columns for purification (SkillPakTM) and continuous chromatography systems (Octave®). Tosoh aims to become a total solution provider in the biopharmaceutical manufacturing process.
The expansion plan will allow the company to keep pace with growing demand. Together with the augmentation of its related product lineup, Tosoh will continue to expand its business.
Topics
Organizations
Other news from the department manufacturing

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Evident to accelerate its growth and innovation - Olympus Agree on Transfer of Evident to Bain Capital
Breakthrough: Scientists harness the power of electricity in the brain
Researchers discover how selenium is incorporated into proteins

(How) Cells Talk to Each Other - ISTA Scientists Successfully Model Cell Dynamics
Arginine:glycine_amidinotransferase
Alternative_medicine

IKA G-L | Midi centrifuges | IKA Werke
Molecular simulations confirm role of functional rotation in multidrug resistance
US Army Medical Research Institute of Infectious Diseases (USAMRIID) - Frederick, USA

Mystery of how plants produce oxygen soon solved

Designer organelles bring new functionalities into cells - EMBL scientists create membraneless organelle to build proteins in living cell
